Tiragolumab and atezolizumab in patients with PD-L1 positive non-small-cell lung cancer. Recondo G, Mezquita L. Lancet Oncol 2022;23:695-697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Recondo G, Mezquita L. Tiragolumab and atezolizumab in patients with PD-L1 positive non-small-cell lung cancer. Lancet Oncol 2022;23:695-697.
PMID: 35654050